Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 6 | 2015 | 56 | 1.530 |
Why?
|
| Macrophage Colony-Stimulating Factor | 8 | 2020 | 13 | 1.340 |
Why?
|
| Arteriosclerosis | 7 | 2004 | 35 | 1.210 |
Why?
|
| Osteoclasts | 2 | 2015 | 13 | 0.770 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 4 | 0.580 |
Why?
|
| Giant Cells | 1 | 2015 | 13 | 0.560 |
Why?
|
| Macrophages | 5 | 2020 | 431 | 0.550 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 22 | 0.550 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2020 | 127 | 0.520 |
Why?
|
| Lipoproteins, LDL | 3 | 2011 | 61 | 0.520 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 88 | 0.400 |
Why?
|
| Estradiol | 1 | 2011 | 244 | 0.360 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 147 | 0.350 |
Why?
|
| Albuminuria | 3 | 2020 | 76 | 0.340 |
Why?
|
| Arteries | 3 | 2004 | 67 | 0.340 |
Why?
|
| Coronary Vessels | 3 | 2005 | 93 | 0.330 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 968 | 0.310 |
Why?
|
| Brachytherapy | 2 | 2004 | 8 | 0.280 |
Why?
|
| Lipoproteins | 1 | 2005 | 61 | 0.260 |
Why?
|
| Endocrine System | 1 | 2004 | 12 | 0.260 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2004 | 14 | 0.240 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 147 | 0.240 |
Why?
|
| Mice | 13 | 2020 | 5668 | 0.240 |
Why?
|
| Coronary Restenosis | 2 | 2004 | 26 | 0.230 |
Why?
|
| Animals | 20 | 2020 | 14307 | 0.230 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 406 | 0.230 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 197 | 0.230 |
Why?
|
| Bone and Bones | 1 | 2003 | 89 | 0.230 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 120 | 0.230 |
Why?
|
| Osteopetrosis | 2 | 2002 | 3 | 0.220 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 4 | 0.220 |
Why?
|
| Receptors, LDL | 2 | 2020 | 30 | 0.210 |
Why?
|
| Immunoblotting | 2 | 2016 | 170 | 0.190 |
Why?
|
| Cell Membrane | 1 | 2002 | 360 | 0.190 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1300 | 0.190 |
Why?
|
| Mice, Knockout | 4 | 2020 | 897 | 0.190 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 84 | 0.180 |
Why?
|
| Monocytes | 4 | 2011 | 258 | 0.180 |
Why?
|
| Inflammation | 2 | 2003 | 577 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2020 | 131 | 0.170 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 53 | 0.170 |
Why?
|
| Models, Biological | 1 | 2002 | 642 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2020 | 296 | 0.170 |
Why?
|
| Male | 13 | 2020 | 18870 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 1530 | 0.160 |
Why?
|
| Cells, Cultured | 6 | 2011 | 1442 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 445 | 0.150 |
Why?
|
| Humans | 16 | 2020 | 34853 | 0.140 |
Why?
|
| Rabbits | 1 | 2016 | 278 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1149 | 0.130 |
Why?
|
| Female | 8 | 2020 | 19873 | 0.130 |
Why?
|
| Middle Aged | 5 | 2020 | 9642 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2014 | 91 | 0.120 |
Why?
|
| Aged | 4 | 2020 | 6448 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 231 | 0.120 |
Why?
|
| Apoptosis | 1 | 2020 | 1317 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 1534 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 592 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 5 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 47 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2004 | 59 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 65 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2011 | 58 | 0.100 |
Why?
|
| Apolipoproteins E | 3 | 2011 | 129 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2011 | 56 | 0.100 |
Why?
|
| Cell Differentiation | 3 | 2008 | 562 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2011 | 115 | 0.100 |
Why?
|
| Rats | 3 | 2016 | 3261 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2333 | 0.090 |
Why?
|
| Muscle Development | 1 | 2008 | 44 | 0.080 |
Why?
|
| Follistatin | 1 | 2008 | 27 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 183 | 0.080 |
Why?
|
| beta Catenin | 1 | 2008 | 46 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 87 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 122 | 0.080 |
Why?
|
| Time Factors | 1 | 2011 | 1681 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2011 | 874 | 0.070 |
Why?
|
| Muscle, Smooth | 2 | 1997 | 51 | 0.070 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 228 | 0.070 |
Why?
|
| Tunica Intima | 2 | 2004 | 21 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 2 | 1997 | 103 | 0.070 |
Why?
|
| Penis | 2 | 1997 | 72 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 9 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2005 | 38 | 0.070 |
Why?
|
| Methods | 1 | 2005 | 12 | 0.070 |
Why?
|
| Preservation, Biological | 1 | 2005 | 3 | 0.070 |
Why?
|
| Lipoproteins, VLDL | 1 | 2005 | 3 | 0.070 |
Why?
|
| Anion Exchange Resins | 1 | 2005 | 4 | 0.070 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 46 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 1998 | 484 | 0.070 |
Why?
|
| Swine | 2 | 2004 | 182 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2005 | 43 | 0.070 |
Why?
|
| Specimen Handling | 1 | 2005 | 49 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 43 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 211 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 24 | 0.060 |
Why?
|
| Echocardiography | 1 | 2005 | 144 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2004 | 5 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2004 | 44 | 0.060 |
Why?
|
| Catheterization | 1 | 2004 | 23 | 0.060 |
Why?
|
| Bone Development | 1 | 2003 | 15 | 0.060 |
Why?
|
| Cholesterol | 1 | 2005 | 194 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 135 | 0.060 |
Why?
|
| Aorta | 2 | 2020 | 161 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 430 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 68 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2004 | 834 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 859 | 0.060 |
Why?
|
| Obesity | 1 | 2011 | 965 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 75 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2002 | 139 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2002 | 52 | 0.050 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2002 | 4 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 206 | 0.050 |
Why?
|
| Catalysis | 1 | 2002 | 162 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2002 | 13 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2002 | 1152 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 60 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2002 | 423 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 296 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2002 | 392 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 325 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2020 | 48 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 64 | 0.050 |
Why?
|
| Cadherins | 1 | 2020 | 82 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2020 | 116 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2003 | 469 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2020 | 1802 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 287 | 0.050 |
Why?
|
| Urinalysis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Creatinine | 1 | 2019 | 101 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 424 | 0.040 |
Why?
|
| Adult | 3 | 2020 | 11034 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 33 | 0.040 |
Why?
|
| Homozygote | 1 | 1998 | 75 | 0.040 |
Why?
|
| Heterozygote | 1 | 1998 | 91 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 423 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2002 | 1349 | 0.040 |
Why?
|
| Colony-Stimulating Factors | 2 | 1989 | 4 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 727 | 0.040 |
Why?
|
| Child | 1 | 2005 | 2875 | 0.040 |
Why?
|
| Penile Erection | 1 | 1997 | 18 | 0.040 |
Why?
|
| DNA | 2 | 1998 | 549 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 1996 | 4 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 1998 | 145 | 0.040 |
Why?
|
| Mutation | 2 | 1998 | 1023 | 0.040 |
Why?
|
| Incidence | 1 | 2019 | 882 | 0.040 |
Why?
|
| Sertoli Cells | 1 | 1996 | 43 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 841 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1996 | 125 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 522 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 137 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2561 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 351 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 3414 | 0.030 |
Why?
|
| Aging | 1 | 1997 | 639 | 0.030 |
Why?
|
| Selenomethionine | 1 | 2011 | 10 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2011 | 18 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 31 | 0.030 |
Why?
|
| Base Sequence | 3 | 1998 | 932 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 72 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 93 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 74 | 0.020 |
Why?
|
| United States | 1 | 2020 | 3894 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 217 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 139 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 1997 | 881 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 8 | 0.020 |
Why?
|
| Neurons | 1 | 1997 | 1130 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1989 | 29 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 14 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 16 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 16 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 33 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1989 | 165 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1998 | 39 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 286 | 0.020 |
Why?
|
| Transfection | 2 | 1998 | 496 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 1997 | 48 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 391 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 338 | 0.020 |
Why?
|
| Growth Substances | 1 | 1985 | 16 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 15 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 1490 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2004 | 46 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 33 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 47 | 0.020 |
Why?
|
| Pyrophosphatases | 1 | 2004 | 7 | 0.020 |
Why?
|
| E-Selectin | 1 | 2004 | 19 | 0.020 |
Why?
|
| Tunica Media | 1 | 2004 | 14 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2004 | 19 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 2004 | 6 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2004 | 24 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 58 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 26 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 92 | 0.020 |
Why?
|
| Cell Line | 2 | 1998 | 1289 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 4012 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2004 | 149 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 72 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 68 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 109 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 135 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 82 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2004 | 105 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 145 | 0.010 |
Why?
|
| Lipids | 1 | 2004 | 222 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 180 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 229 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 650 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 486 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 638 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1997 | 1124 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1998 | 16 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1998 | 103 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 465 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 164 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 27 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1997 | 12 | 0.010 |
Why?
|
| Codon | 1 | 1997 | 38 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1997 | 26 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1996 | 16 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 204 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1998 | 252 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 310 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1997 | 128 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 286 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 480 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1995 | 12 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1995 | 14 | 0.010 |
Why?
|
| Nifedipine | 1 | 1995 | 12 | 0.010 |
Why?
|
| Guanidines | 1 | 1995 | 17 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 34 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1995 | 30 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 31 | 0.010 |
Why?
|
| Testosterone | 1 | 1996 | 181 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1995 | 43 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 485 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1998 | 301 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1997 | 306 | 0.010 |
Why?
|
| Gene Expression | 1 | 1996 | 639 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1995 | 287 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1989 | 8 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1989 | 155 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1985 | 2 | 0.000 |
Why?
|
| Lymphokines | 1 | 1985 | 11 | 0.000 |
Why?
|
| Trypsin | 1 | 1985 | 39 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1985 | 43 | 0.000 |
Why?
|
| Carbohydrates | 1 | 1985 | 28 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 64 | 0.000 |
Why?
|
| Organic Chemicals | 1 | 1985 | 35 | 0.000 |
Why?
|
| Amino Acids | 1 | 1985 | 139 | 0.000 |
Why?
|
| Insulin | 1 | 1985 | 224 | 0.000 |
Why?
|